Home > Insider Trading > Filing (0000896262-21-000002)

Filing Details

Accession Number:: 0000896262-21-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-01-05 17:58:32
Reporting Period:: 2020-12-31

Accepted Time:: 2021-01-05 17:58:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896262	Amedisys Inc	AMED	Services-Home Health Care Services (8082)	113131700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543701	G Scott Ginn	3854 American Way, Suite A Baton Rouge LA 70816	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-12-31	225	$27.35	18,074	No	4	M	Direct
Common Stock	Acquisiton	2020-12-31	750	$27.35	18,824	No	4	M	Direct
Common Stock	Disposition	2020-12-31	975	$287.57	17,849	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-12-31	225	$0.00	225	$27.35
Common Stock	Stock Option (Right to Buy)	Disposition	2020-12-31	750	$0.00	750	$27.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-05-01	No	4	M	Direct
4,875		2025-05-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,714	Indirect	Through 401(k) Plan

Footnotes

The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The information in this report is based on a plan statement dated as of September 30, 2020.
On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2017 were met, resulting in vesting of the option as to 5,625 shares (the "2017 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2017 Tranche Options vested on May 1, 2018, one-third of the 2017 Tranche Options vested on May 1, 2019 and one-third of the 2017 Tranche Options vested on May 1, 2020. After the transactions reported in this Form 4, all of the 2017 Tranche Options have been exercised.
On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 5,625 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019 and two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transactions reported in this Form 4, 4,875 of the 2018 Tranche Options remain unexercised.